Gregg Bolotin, MD
Emergency Medicine · Chula Vista, CANPI 1366451601
Payments from drug & device makers
Across 15 payments — averaging $27.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$177
- Pfizer$121
- Johnson & Johnson$39
- CSL Behring$34
- Neurocrine Biosciences, Inc.$19
- Kiniksa Pharmaceuticals, Ltd.$14
- plus $12 from 1 others
What the payments were for
- Food & beverage$40397%
- Education$123%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 2 | $177 |
| Pfizer | 6 | $121 |
| Johnson & Johnson | 3 | $39 |
| CSL Behring | 1 | $34 |
| Neurocrine Biosciences, Inc. | 1 | $19 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $14 |
| Paratek Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$415 in reported general payments places this provider in the 85th percentile of 6,006 emergency medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 18 | $414 |
| CefuroximeCefuroxime Axetil | 30 | $334 |
| Methylprednisolone | 38 | $299 |
| Ciprofloxacin Hcl | 35 | $218 |
| Ondansetron Hcl | 36 | $212 |
| Cephalexin | 24 | $144 |
| Doxycycline Hyclate | 12 | $136 |
| Gabapentin | 14 | $116 |
| Promethazine Hcl | 29 | $113 |
| Oxycodone Hcl | 46 | $75 |
| Sucralfate | 15 | $75 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $74 |
| Meclizine Hcl | 21 | $57 |
| Prednisone | 12 | $56 |
| Ibuprofen | 11 | $48 |
Paid to pharmacies, not to this prescriber.
Other emergency medicine in Chula Vista
- Jeffrey OvercashChula Vista$31.8M
- Michael WatersChula Vista$13.3M
- Todd SimmonsEscondido$19.9M
- Barry HellerLong Beach$11.5M
- Gregory HachigianSacramento$10.9M
- Masaru OshitaSacramento$7.9M
- Brian BearieSan Bernardino$6.5M
- Julie KasarjianRiverside$4.9M
- Anna Ryabets-LienhardLos Angeles$3M
- Justin YanuckDowney$2.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.